Plant Impact Regulatory News (PIM)

For Immediate Release 3 July 2015

Plant Impact plc

("Plant Impact" or the "Company")

Directors Dealing and Total Voting Rights

Plant Impact plc (AIM: PIM), an agricultural bioscience company that develops and markets crop enhancement and speciality nutrition products, provides the following update regarding the exercise of Unapproved Share Options ("Options") by Dr David Jones, the Company's Chairman.

On 2 July 2015, the Company was notified by Dr Jones of his intention to exercise 1,375,000 Options at a cost of 25.5 pence per ordinary share in the Company ("Ordinary Shares") only conditional upon the admission of the block listing shares anticipated to commence on or around 8 July 2015. Dr Jones will not sell any Ordinary Shares to fund this purchase, but may do so in the next 12 months to cover related tax liabilities.

With this proposed acquisition, Dr Jones's beneficial holding in the Company will increase to 2,197,571 Ordinary Shares, representing 2.70% of the enlarged share capital. 

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company confirms that, following the issue of 1,375,000 Ordinary Shares expected to commence on or around 8 July 2015, the issued share capital of the Company will be 81,395,400 Ordinary Shares with voting rights attached (one vote per Ordinary Share).

Enquiries:

Plant Impact plc

John Brubaker, Chief Executive Tel: +44(0) 1582 465 540

Kate Barnes-Quinn, Finance Director

www.plantimpact.com

Peel Hunt LLP, Nomad / Broker

Dan Webster / Richard Brown / George Sellar Tel: +44 (0) 20 7418 8900

Buchanan

Charles Ryland / Sophie Cowles / Jane Glover Tel: +44 (0) 20 7920 3150